Page last updated: 2024-08-17

egtazic acid and cardiovascular agents

egtazic acid has been researched along with cardiovascular agents in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikejima, K; Qu, W; Thurman, RG; Waalkes, MP; Zhong, Z1
Brown, JT; Randall, AD1
Araki, E; Fukuda, K; Ishii, N; Kawada, T; Kim-Mitsuyama, S; Kinoshita, H; Matsumura, T; Miyamura, N; Motoshima, H; Nakao, S; Nishikawa, T; Senokuchi, T; Takeya, M; Tsutsumi, A1

Other Studies

3 other study(ies) available for egtazic acid and cardiovascular agents

ArticleYear
Glycine blocks the increase in intracellular free Ca2+ due to vasoactive mediators in hepatic parenchymal cells.
    American journal of physiology. Gastrointestinal and liver physiology, 2002, Volume: 283, Issue:6

    Topics: Adrenergic alpha-Agonists; Animals; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Cell Membrane; Cells, Cultured; Chloride Channels; Dinoprostone; Dose-Response Relationship, Drug; Egtazic Acid; Female; Gallic Acid; Glycine; Heparin; Liver; Phenylephrine; Rats; Rats, Sprague-Dawley

2002
Activity-dependent depression of the spike after-depolarization generates long-lasting intrinsic plasticity in hippocampal CA3 pyramidal neurons.
    The Journal of physiology, 2009, Mar-15, Volume: 587, Issue:Pt 6

    Topics: Action Potentials; Animals; Anthracenes; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Signaling; Carbamates; Cardiovascular Agents; Chelating Agents; Egtazic Acid; Hippocampus; In Vitro Techniques; KCNQ Potassium Channels; Male; Membrane Potentials; Neuronal Plasticity; Patch-Clamp Techniques; Phenylenediamines; Pyramidal Cells; Pyrimidines; Rats; Rats, Wistar

2009
Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:8

    Topics: Amlodipine; Animals; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Cardiovascular Agents; Cells, Cultured; Chelating Agents; Chemokine CCL2; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Flavonoids; Humans; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Nifedipine; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; RNA Interference; RNA, Messenger; Time Factors; Transfection

2010